(Q45960012)

English

Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization.

scientific article published on 22 June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

multiple myeloma

1 reference

based on heuristic

inferred from title

author name string

G Tricot

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

M H Cottler-Fox

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

G Calandra

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

language of work or name

0 references

publication date

22 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

45

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

63-68

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

https://scigraph.springernature.com/pub.10.1038/bmt.2009.130

0 references

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

21 January 2018

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

21 January 2018

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

21 January 2018

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

21 January 2018

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

21 January 2018

Cytoplasmic immunoglobulin content in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

21 January 2018

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

21 January 2018

Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

21 January 2018

Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

21 January 2018

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilisation of tumour cells along with CD34+ cells to peripheral blood in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

7 January 2021

based on heuristic

inferred from DOI database lookup

First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.130

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2009.130

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19543330

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45960012&oldid=1522562306"